Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 32017R0195

Commission Implementing Regulation (EU) 2017/195 of 3 February 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of several active substances listed in Part B of the Annex to Implementing Regulation (EU) No 686/2012 (AIR IV renewal programme) (Text with EEA relevance. )

C/2017/0512

OJ L 31, 4.2.2017, p. 21–24 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

Legal status of the document In force

ELI: http://data.europa.eu/eli/reg_impl/2017/195/oj

Date of document:
03/02/2017; Date of adoption
Date of effect:
24/02/2017; Entry into force Date pub. +20 See Art 2
Date of end of validity:
No end date
Author:
European Commission
Responsible body:
SANTE
Form:
Implementing regulation
Additional information:
EEA relevance
Treaty:
Treaty on the Functioning of the European Union
Legal basis:
Link
Link
Link
Select all documents mentioning this document
Modifies:
Relation Act Comment Subdivision concerned From To
Modifies 32011R0540 Replacement annex P. A Text 24/02/2017
Modifies 32011R0540 Replacement annex P. B Text 24/02/2017
Instruments cited:
Link

4.2.2017   

EN

Official Journal of the European Union

L 31/21

COMMISSION IMPLEMENTING REGULATION (EU) 2017/195

of 3 February 2017

amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of several active substances listed in Part B of the Annex to Implementing Regulation (EU) No 686/2012 (AIR IV renewal programme)

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (1), and in particular the first paragraph of Article 17 thereof,

Whereas:

(1)

Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 (2) sets out the active substances deemed to have been approved under Regulation (EC) No 1107/2009. Part B of the Annex to Implementing Regulation (EU) No 540/2011 sets out the active substances approved under Regulation (EC) No 1107/2009.

(2)

Applications for the renewal of the approval of the active substances included in this Regulation were submitted in accordance with Commission Implementing Regulation (EU) No 844/2012 (3). However, the approval of those substances may expire for reasons beyond the control of the applicant before a decision has been taken on the renewal of their approval. It is therefore necessary to extend their approval periods in accordance with Article 17 of Regulation (EC) No 1107/2009.

(3)

In view of the time and resources necessary for completing the assessment of applications for the renewal of approvals of the large number of active substances the approvals of which are expiring between 2019 and 2021, Commission Implementing Decision C(2016)6104 (4) established a work programme grouping together similar active substances and setting priorities on the basis of safety concerns for human and animal health or the environment as provided for in Article 18 of Regulation (EC) No 1107/2009.

(4)

The presumed low risk substances should be prioritised in accordance with Implementing Decision C(2016)6104. The approval of those substances should therefore be extended by a period as short as possible. Taking into account the distribution of responsibilities and work among Member States acting as rapporteurs and co-rapporteurs and the available resources necessary for assessment and decision-making, that period should be of one year for the active substances aluminium ammonium sulphate, aluminium silicate, blood meal, calcium carbonate, carbon dioxide, extract from tea tree, fat distilation residues, fatty acids c7 to c20, garlic extract, gibberellic acid, gibberellin, hydrolysed proteins, iron sulphate, kieselgur (diatomaceous earth), pepper dust extraction residue (PDER), plant oils/rape seed oil, potassium hydrogen carbonate, quartz sand, fish oil, repellents by smell of animal or plant origin/sheep fat, repellents by smell of animal or plant origin/tall oil crude, repellents by smell of animal or plant origin/tall oil pitch, sodium aluminium silicate, straight chain lepidopteran pheromones, and urea.

(5)

For active substances which do not fall in the prioritised categories in Implementing Decision C(2016)6104, the approval period should be extended by either two or three years, taking into account the present date of expiry, the fact that according to Article 6(3) of Implementing Regulation (EU) No 844/2012 the supplementary dossier for an active substance shall be submitted no later than 30 months before expiry of the approval, the need to ensure a balanced distribution of responsibilities and work among Member States acting as rapporteurs and co-rapporteurs and the available resources necessary for assessment and decision-making. It is therefore appropriate to extend the approval periods for bifenthrin, cymoxanil and metazachlor by two years, and to extend the approval periods of active substances 2,5-dichlorobenzoic acid methylester, acetic acid, aclonifen, aluminium phosphide, calcium carbide, calcium phosphide, denathonium benzoate, dodemorph, ethylene, imidacloprid, magnesium phosphide, metamitron, plant oils/citronella oil, plant oils/clove oil, plant oils/spear mint oil, pyrethrins, and sulcotrione by three years.

(6)

In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where no supplementary dossier in accordance with Implementing Regulation (EU) No 844/2012 is submitted no later than 30 months before the respective expiry date laid down in the Annex to this Regulation, the Commission will set the expiry date at the same date as before this Regulation or at the earliest date thereafter.

(7)

In view of the aim of the first paragraph of Article 17 of Regulation (EC) No 1107/2009, as regards cases where the Commission will adopt a Regulation providing that the approval of an active substance referred to in the Annex to this Regulation is not renewed because the approval criteria are not satisfied, the Commission will set the expiry date at the same date as before this Regulation or at the date of the entry into force of the Regulation providing that the approval of the active substance is not renewed, whichever date is later. As regards cases where the Commission will adopt a Regulation providing for the renewal of an active substance referred to in the Annex to this Regulation, the Commission will endeavour to set, as appropriate under the circumstances, the earliest possible application date.

(8)

Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.

(9)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

HAS ADOPTED THIS REGULATION:

Article 1

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 3 February 2017.

For the Commission

The President

Jean-Claude JUNCKER

(1)   OJ L 309, 24.11.2009, p. 1.

(2)  Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances (OJ L 153, 11.6.2011, p. 1).

(3)  Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 252, 19.9.2012, p. 26).

(4)  Commission Implementing Decision of 28 September 2016 on the establishment of a work programme for the assessment of applications for the renewal of approvals of active substances expiring in 2019, 2020 and 2021 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council (OJ C 357, 29.9.2016, p. 9).

ANNEX

The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(A)

Part A is amended as follows:

(1)

in the sixth column, expiration of approval, of row 215, Aclonifen, the date is replaced by ‘31 July 2022’;

(2)

in the sixth column, expiration of approval, of row 216, Imidacloprid, the date is replaced by ‘31 July 2022’;

(3)

in the sixth column, expiration of approval, of row 217, Metazachlor, the date is replaced by ‘31 July 2021’;

(4)

in the sixth column, expiration of approval, of row 218, Acetic acid, the date is replaced by ‘31 August 2022’;

(5)

in the sixth column, expiration of approval, of row 219, Aluminium ammonium sulphate, the date is replaced by ‘31 August 2020’;

(6)

in the sixth column, expiration of approval, of row 220, Aluminium silicate, the date is replaced by ‘31 August 2020’;

(7)

in the sixth column, expiration of approval, of row 222, Blood meal, the date is replaced by ‘31 August 2020’;

(8)

in the sixth column, expiration of approval, of row 223, Calcium carbide, the date is replaced by ‘31 August 2022’;

(9)

in the sixth column, expiration of approval, of row 224, Calcium carbonate, the date is replaced by ‘31 August 2020’;

(10)

in the sixth column, expiration of approval, of row 225, Carbon dioxide, the date is replaced by ‘31 August 2020’;

(11)

in the sixth column, expiration of approval, of row 226, Denathonium benzoate, the date is replaced by ‘31 August 2022’;

(12)

in the sixth column, expiration of approval, of row 227, Ethylene, the date is replaced by ‘31 August 2022’;

(13)

in the sixth column, expiration of approval, of row 228, Extract from tea tree, the date is replaced by ‘31 August 2020’;

(14)

in the sixth column, expiration of approval, of row 229, Fat distilation residues, the date is replaced by ‘31 August 2020’;

(15)

in the sixth column, expiration of approval, of row 230, Fatty acids C7 to C20, the date is replaced by ‘31 August 2020’;

(16)

in the sixth column, expiration of approval, of row 231, Garlic extract, the date is replaced by ‘31 August 2020’;

(17)

in the sixth column, expiration of approval, of row 232, Gibberellic acid, the date is replaced by ‘31 August 2020’;

(18)

in the sixth column, expiration of approval, of row 233, Gibberellin, the date is replaced by ‘31 August 2020’;

(19)

in the sixth column, expiration of approval, of row 234, Hydrolysed proteins, the date is replaced by ‘31 August 2020’;

(20)

in the sixth column, expiration of approval, of row 235, Iron sulphate, the date is replaced by ‘31 August 2020’;

(21)

in the sixth column, expiration of approval, of row 236, Kieselgur (diatomaceous earth), the date is replaced by ‘31 August 2020’;

(22)

in the sixth column, expiration of approval, of row 239, Pepper dust extraction residue (PDER), the date is replaced by ‘31 August 2020’;

(23)

in the sixth column, expiration of approval, of row 240, Plant oils/Citronella oil, the date is replaced by ‘31 August 2022’;

(24)

in the sixth column, expiration of approval, of row 241, Plant oils/Clove oil, the date is replaced by ‘31 August 2022’;

(25)

in the sixth column, expiration of approval, of row 242, Plant oils/Rape seed oil, the date is replaced by ‘31 August 2020’;

(26)

in the sixth column, expiration of approval, of row 243, Plant oils/Spear mint oil, the date is replaced by ‘31 August 2022’;

(27)

in the sixth column, expiration of approval, of row 244, Potassium hydrogen carbonate, the date is replaced by ‘31 August 2020’;

(28)

in the sixth column, expiration of approval, of row 246, Pyrethrins, the date is replaced by ‘31 August 2022’;

(29)

in the sixth column, expiration of approval, of row 247, Quartz sand, the date is replaced by ‘31 August 2020’;

(30)

in the sixth column, expiration of approval, of row 248, Fish oil, the date is replaced by ‘31 August 2020’;

(31)

in the sixth column, expiration of approval, of row 249, Repellents by smell of animal or plant origin/sheep fat, the date is replaced by ‘31 August 2020’;

(32)

in the sixth column, expiration of approval, of row 250, Repellents by smell of animal or plant origin/tall oil crude, the date is replaced by ‘31 August 2020’;

(33)

in the sixth column, expiration of approval, of row 251, Repellents by smell of animal or plant origin/tall oil pitch, the date is replaced by ‘31 August 2020’;

(34)

in the sixth column, expiration of approval, of row 253, Sodium aluminium silicate, the date is replaced by ‘31 August 2020’;

(35)

in the sixth column, expiration of approval, of row 255, Straight Chain Lepidopteran Pheromones, the date is replaced by ‘31 August 2020’;

(36)

in the sixth column, expiration of approval, of row 257, Urea, the date is replaced by ‘31 August 2020’;

(37)

in the sixth column, expiration of approval, of row 260, Aluminium phosphide, the date is replaced by ‘31 August 2022’;

(38)

in the sixth column, expiration of approval, of row 261, Calcium phosphide, the date is replaced by ‘31 August 2022’;

(39)

in the sixth column, expiration of approval, of row 262, Magnesium phosphide, the date is replaced by ‘31 August 2022’;

(40)

in the sixth column, expiration of approval, of row 263, Cymoxanil, the date is replaced by ‘31 August 2021’;

(41)

in the sixth column, expiration of approval, of row 264, Dodemorph, the date is replaced by ‘31 August 2022’;

(42)

in the sixth column, expiration of approval, of row 265, 2,5-Dichlorobenzoic acid methylester, the date is replaced by ‘31 August 2022’;

(43)

in the sixth column, expiration of approval, of row 266, Metamitron, the date is replaced by ‘31 August 2022’;

(44)

in the sixth column, expiration of approval, of row 267, Sulcotrione, the date is replaced by ‘31 August 2022’;

(B)

In Part B, in the sixth column, expiration of approval, of row 23, Bifenthrin, the date is replaced by ‘31 July 2021’.
Top